Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

346
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Seizures: Classification01:13

Seizures: Classification

413
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
413
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

214
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
214
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

8.3K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

461
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
461

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein-enhanced small molecule disruptors of ordered membrane domains.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Excitatory Dysfunction and Phenotypic Rescue in a Human Neuronal Model of <i>SCN2A</i>-Related Disorders.

bioRxiv : the preprint server for biology·2026
Same author

Combining automated patch clamp with optogenetics enables selective recording of DRG neurons subtypes.

bioRxiv : the preprint server for biology·2026
Same author

An upstream open reading frame represses translation of the neuronal potassium channel KCNQ2.

bioRxiv : the preprint server for biology·2026
Same author

SCN2A variants are associated with familial and sporadic hemiplegic migraine.

Brain : a journal of neurology·2026
Same author

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jul 19, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.9K

Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties.

Christopher H Thompson1, Franck Potet1, Tatiana V Abramova1

  • 1Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

The Journal of General Physiology
|August 14, 2023
PubMed
Summary

Pathogenic SCN2A variants, linked to neurodevelopmental disorders, show complex functional changes. Automated patch-clamp recording reveals these variants often have mixed gain- and loss-of-function effects, challenging simple classifications.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.8K
Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
04:41

Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research

Published on: October 13, 2023

1.6K

Related Experiment Videos

Last Updated: Jul 19, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.9K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.8K
Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
04:41

Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research

Published on: October 13, 2023

1.6K

Area of Science:

  • Neurogenetics
  • Ion Channel Physiology
  • Developmental Neuroscience

Background:

  • Pathogenic variants in voltage-gated sodium channel genes, particularly SCN2A (encoding NaV1.2), are frequently implicated in neurodevelopmental disorders, including epilepsy, autism spectrum disorder (ASD), and intellectual disability (ID).
  • A prevailing model suggested a dichotomy where gain-of-function variants cause epilepsy and loss-of-function variants lead to ASD/ID, but this was based on limited, heterogeneous data.
  • The functional consequences of most disease-associated SCN2A variants remain uncharacterized, necessitating standardized, high-throughput methods for comprehensive analysis.

Purpose of the Study:

  • To validate automated patch-clamp recording as a high-throughput method for assessing SCN2A variant function under uniform conditions.
  • To investigate whether a binary classification of variant dysfunction (gain- vs. loss-of-function) holds true for a larger cohort of SCN2A variants.
  • To explore the complex functional properties of NaV1.2 variants associated with neurodevelopmental disorders.

Main Methods:

  • Utilized automated patch-clamp electrophysiology to record the functional properties of 28 disease-associated and 4 common SCN2A variants.
  • Expressed two alternatively spliced isoforms of NaV1.2 in HEK293T cells for variant analysis.
  • Compared automated patch-clamp findings with previously published manual patch-clamp data for validation.

Main Results:

  • Automated patch-clamp recording proved to be a valid and high-throughput method, yielding results concordant with prior manual patch-clamp studies.
  • Many epilepsy-associated SCN2A variants displayed complex functional profiles, exhibiting both gain- and loss-of-function characteristics that defy simple binary categorization.
  • The study demonstrated the feasibility of analyzing a larger number of variants under standardized conditions, enhancing experimental rigor and reducing operator bias.

Conclusions:

  • The functional consequences of SCN2A variants are more complex than previously assumed, often presenting mixed gain- and loss-of-function phenotypes.
  • Automated patch-clamp electrophysiology is a robust and scalable method for detailed functional annotation of ion channel variants.
  • This approach facilitates a more nuanced understanding of genotype-phenotype correlations in neurodevelopmental disorders linked to SCN2A dysfunction.